Concepedia

Robert A. Reamer

RA

Statistics

Publications

149

Citations

7.7K

H-Index

50

Active since

1978

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Biopharma Co., Ltd. (Japan)

Robert A. Reamer is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in chemistry, medicinal chemistry, and natural sciences.

Publications per year

1978–2017

149

Publications

149

A New Planar Chiral Bisphosphine Ligand for Asymmetric Catalysis:  Highly Enantioselective Hydrogenations under Mild Conditions

Philip J. Pye, Kai Rossen, Robert A. Reamer et al. · Journal of the American Chemical Society · 1997 · 373 citations

, , +10

A practical enantioselective synthesis of .alpha.,.alpha.-diaryl-2-pyrrolidinemethanol. Preparation and chemistry of the corresponding oxazaborolidines

David J. Mathre, Todd K. Jones, Lyndon C. Xavier et al. · The Journal of Organic Chemistry · 1991 · 228 citations

, , +8

Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor

Michael E. Pierce, Rodney L. Parsons, Lilian Radesca et al. · The Journal of Organic Chemistry · 1998 · 215 citations

, , +16

Highly diastereoselective alkylations of chiral amide enolates: new routes to hydroxyethylene dipeptide isostere inhibitors of HIV-1 protease

D. Askin, M A Wallace, Joseph P. Vacca et al. · The Journal of Organic Chemistry · 1992 · 195 citations

, , +6

Efficient Synthesis of Losartan, A Nonpeptide Angiotensin II Receptor Antagonist

Robert D. Larsen, Anthony O. King, Cheng‐Yu Chen et al. · The Journal of Organic Chemistry · 1994 · 193 citations

, , +8

1–5 of 149